Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Hims & Hers (NASDAQ: HIMS) stock has done well since the company went public a few years ago. It has soared by over 193% in ...

Hims & Hers is a fantastic value despite its high 'on-the-surface' P/E ratio and valuation metrics. The company's subscription-based model in healthcare, targeting chronic conditions, ensures ...

Multiple online telehealth companies offer ED medication online. It is important only to use companies offering online consultations with a licensed medical professional. Hims is also a telehealth ...

“90 Day Fiancé” star Ed “Big Ed” Brown says it was “love at first sight” with now-fiancée Porscha Raemond, whom he proposed to 24 hours after meeting in Plantation, Fla., last Friday.

Each year, the National Drug and Alcohol Research Centre at UNSW Sydney surveys hundreds of people who regularly use drugs in Australia to understand trends in substance use around the country.

for a hearing next week that will focus on hearing popular drugs, Ozempic, and Wegovy in the U.S. Price Action: HIMS stock is up 3.49% at $16.88 at last check Thursday.

NEW YORK (Reuters) - U.S. telehealth company Hims & Hers Health on Wednesday said ... Soaring demand for weight-loss drugs in the GLP-1 class, which have been shown to help patients lose as ...

and compounding pharmacies for allegedly selling products claiming to contain the active ingredients in their drugs. Compounded GLP-1 injections are fulfilled and shipped from Hims & Hers ...